Key result
The 2024 ESC guidelines recommend initiating antihypertensive drug treatment at lower blood pressure thresholds (120-139/70-89 mmHg) than the 2023 ESH guidelines (>140/90 mmHg), which the authors argue lacks strong trial-based evidence.
Answers are grounded in this paper and cite their sources.
This editorial challenges the 2024 ESC hypertension guidelines, arguing that their lower blood pressure thresholds for initiating pharmacological treatment lack robust randomized trial evidence.
One of the most important recommendations from the guidelines on hypertension is to decide when to lower blood pressure through antihypertensive treatment...
No takes yet. Share an insight, caveat, or question.
Mancia et al. (2025) conducted an editorial in Hypertension. Antihypertensive drug treatment was evaluated. The 2024 ESC guidelines recommend initiating antihypertensive drug treatment at lower blood pressure thresholds (120-139/70-89 mmHg) than the 2023 ESH guidelines (>140/90 mmHg), which the authors argue lacks strong trial-based evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: